Growing Adoption of SGLT2 Inhibitors Reshapes the Global Diabetes Treatment Landscape
The global SGLT2 Inhibitors Market is rapidly evolving as pharmaceutical companies develop therapies that address not only diabetes but also cardiovascular and renal health. According to Polaris Market Research, the market is projected to grow from USD 19.57 billion in 2026 to USD 33.51 billion by 2034, achieving a CAGR of 6.9%. Increasing clinical evidence supporting broader therapeutic...
0 Yorumlar 0 Bölünmüş 9 Görüntülemeler 0 Yorumlar